Indexes Rise Again, But Wait For More. TransDigm, Neurocrine, Chipotle In Focus.
Listen now
Description
The indexes rose solidly for a second straight session, but don’t get excited yet by the nascent rally attempt, especially with earnings season kicking into high gear. TransDigm is on the cusp of a buy signal amid strength in aerospace names. Neurocrine Biosciences jumped toward possible entries on positive drug news. Chipotle is setting up nicely with earnings on tap.
More Episodes
The ADP employment came in weaker than expected, raising expectations that the first Federal Reserve rate cut will come at the September meeting. Friday’s employment report still looms large. CrowdStrike soared after reporting earnings, but there’s a caveat; ASML gapped up to the top of a 13-week...
Published 06/05/24
The major indexes were firm Tuesday, with the Nasdaq and S&P 500 near record highs. But market breadth was weak, with small caps falling back below the 50-day line. Spotify and Novo Nordisk cleared buy points while GE Aerospace is finding key support, working on a new base.
Published 06/04/24
Published 06/04/24